News – Ypsomed Delivery Systems

Ypsomed is looking forward to exhibiting at BIO International Convention 2018 in Boston, Massachusetts from June 4-7.

News – Ypsomed Delivery Systems

The latest issue of Medical Devices: Evidence and Research presents a formative usability study for FixPen, a fixed-dose pen-injector platform device, used primarily for patient self-injection.

News – Ypsomed Delivery Systems

Tune in at the Drug/Device Combination Products Summit in Vienna.

News – Ypsomed Delivery Systems

Listen to us at the PharmaEd pre-filled syringes Meeting in Philadelphia.

News – Ypsomed Delivery Systems

Ypsomed to present “Injection Devices for Biosimilars” at the Biotech Pharma Summit 2018 in Porto.

New article published in ONdrugDELIVERY

News – Ypsomed Delivery Systems

This article provides insights into the development of platform products that offer pharma companies low risks and shorter timelines at an attractive cost.

News – Ypsomed Delivery Systems

Ypsomed Delivery Systems is showcasing its complete range of self-injection devices at the upcoming Pharmapack Europe.

Past research has emphasized injection force as a clinically highly relevant technical attribute of pen devices. However, little work has been conducted to relate these results to in-use studies.

California, USA, 7-8 December 2017

News – Ypsomed Delivery Systems

Jakob Lange, Key Account Director Delivery Systems, will give a presentation about the trends in self-injection: Large volume autoinjectors, wearable devices and connectivity in self-injection.

In this article, Andreas Schneider, PhD, Business Development at Ypsomed, outlines how smart injection systems can be used for remote monitoring of medication adherence during clinical trials. He shows how the key challenges of clinical research are resolved by introducing advanced adherence monitoring services. In a case study, Dr Schneider describes how such services are realised with SmartPilot for YpsoMate.